Single-point calibration for sirolimus quantification [2]

Therapeutic Drug Monitoring

Volumn 23, Issue 6, 2001, Pages 726-727

  Taylor, P J ^a   Forrest, K K ^a   Salm, P ^a   Pillans, P I ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ACCURACY; ANALYTIC METHOD; CALIBRATION; DRUG BLOOD LEVEL; DRUG MONITORING; LETTER; MEASUREMENT; PRIORITY JOURNAL; QUALITY CONTROL;

CALIBRATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; QUALITY CONTROL; SIROLIMUS;

EID: 0035190418     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200112000-00023     Document Type: Letter

References (9)

1. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
2. 21083A Rapamune (sirolimus) oral solution. Clinical pharmacology and biopharmaceutics review(s)
3. Therapeutic drug monitoring of sirolimus: Correlations with efficacy and toxicity
4. Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatographyelectrospray tandem mass spectrometry
5. Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry
6. Statistical methods for assessing agreement between two methods of clinical measurement
7. Consensus guidelines for therapeutic drug monitoring of rapamycin: Report of the consensus panel
8. Current opinions on therapeutic drug monitoring of immunosuppressive drugs